This is a preview of subscription content, log in via an institution to check access.
References
Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ et al (2015) Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene. Neuropathol Appl Neurobiol 41(5):601–612
Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G et al (2013) Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK Population. Am J Hum Genet. 19:1–9
Ciura S, Lattante S, Le Ber I, Latouche M, Tostivint H, Brice A et al (2013) Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis. Ann Neurol 74(2):180–187
Dejesus-hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ et al (2011) Article expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 72(2):245–256
Farg MA, Sundaramoorthy V, Sultana JM, Yang S, Atkinson RA, Levina V et al (2014) C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum Mol Genet 23(13):3579–3595
Lashley T, Rohrer JD, Mahoney C, Gordon E, Beck J, Mead S et al (2014) A pathogenic progranulin mutation and C9orf72 repeat expansion in a family with frontotemporal dementia. Neuropathol Appl Neurobiol 40:502–513
Proudfoot M, Gutowski NJ, Edbauer D, Hilton DA, Stephens M, Rankin J et al (2014) Early dipeptide repeat pathology in a frontotemporal dementia kindred with C9ORF72 mutation and intellectual disability. Acta Neuropathol. 127(3):451–458
Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR et al (2011) A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 72(2):257–268
Rohrer JD, Isaacs AM, Mizlienska S, Mead S, Lashley T, Wray S et al (2015) C9orf72 expansions in frontotemporal dementia and amyotrophic lateral sclerosis. Lancet Neurol 14(3):291–301
Simón-Sánchez J, Dopper EGP, Cohn-Hokke PE, Hukema RK, Nicolaou N, Seelaar H et al (2012) The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions. Brain 135(Pt 3):723–735
Waite AJ, Bäumer D, East S, Neal J, Morris HR, Ansorge O et al (2014) Reduced C9orf72 protein levels in frontal cortex of amyotrophic lateral sclerosis and frontotemporal degeneration brain with the C9ORF72 hexanucleotide repeat expansion. Neurobiol 35(7):1779.e5–1779.e13 (Aging Elsevier Ltd)
Xi Z, van Blitterswijk M, Zhang M, McGoldrick P, McLean JR, Yunusova Y et al (2015) Jump from pre-mutation to pathologic expansion in C9orf72. Am J Hum Genet 10(5):e0126082
Acknowledgments
We acknowledge funding from the Leonard Wolfson Experimental Neurology Centre (PG), Alzheimer’s Research UK fellowship (TL), Reta Lila Weston Institute for Neurological Studies (JLH). This research was partly supported by the National Institute for Health Research (NIHR) Queen Square Biomedical Research Unit in Dementia based at University College London Hospitals, University College London. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Gami, P., Murray, C., Schottlaender, L. et al. A 30-unit hexanucleotide repeat expansion in C9orf72 induces pathological lesions with dipeptide-repeat proteins and RNA foci, but not TDP-43 inclusions and clinical disease. Acta Neuropathol 130, 599–601 (2015). https://doi.org/10.1007/s00401-015-1473-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-015-1473-5